28May

First multi-site installation of HORIBA Medical’s new HELO modular automated haematology platform

Horibalogo

Northampton, UK – 28th May 2019 – HORIBA UK Ltd, Medical announces the go live of the first multi-site installation of its new HELO high throughput fully automated haematology platform within the Cardiff and Vale University Health Board. The new system is already delivering laboratory efficiencies across Cardiff in line with NHS requirements through the next generation haematology analysers installed at the University Hospital of Wales (UHW) and University Hospital, Llandough. Both sites are fully UKAS accredited to ISO 15189 and networked together by a single virtual server to facilitate highly efficient and secure cross city working.

 

Cardiff upgraded across the city with four new HORIBA Yumizen tracked haematology analysers at UHW and two separate Yumizen analysers at Llandough, both sites have also installed a Slide Preparation System. Through the HELO platform all of these analysers are brought together into a single networked system where results can be remotely authorised. This single service, allowing remote management from one site to the other, has enabled the sites to skill-mix staff successfully and keep within a stringent financial framework.

 

Alun Roderick, Haematology, Blood Transfusion and Phlebotomy Service Manager, Cardiff and Vale University Health Board, said, “The efficiencies that HELO has allowed us is breath-taking. Samples are being processed quicker and we can be more efficient with the way that we deploy staff. Using support staff more and putting our qualified biomedical scientists exactly where they need to be at the right time. This means we can support more specialist laboratories, including blood transfusion, while maintaining the quality of our overall service, but just in a different way.”

 

“We are now able to provide our staff with a broader experience of the laboratory. Rather than just dealing with full blood counts as a factory, our qualified staff now also have the time to work in more interesting specialist areas, such as undertaking immunophenotyping, doing more haemoglobinopathies or specialist coagulation,” Alun added.

 

Using the new HELO platform with Yumizen analysers has allowed Cardiff to review the workflow coming through its laboratories. In addition to the efficiencies gained from having a single service across two sites by applying data management to maximum capacity, using the track-based system enables the analysers to perform optimally. The HELO system automatically disperses samples to the most appropriate analyser, as well as undertakes blood films for example using reflex rules.

 

Alun Roderick also observed the high level of support that HORIBA Medical gave throughout the installation process and beyond. “The installation plan was extremely smooth without disruption to the laboratory and the support offered has been first class. HORIBA worked with us in partnership every step of the way to produce all the vital validation and verification documentation, as well as the staff training with ongoing competencies needed for us to maintain our ISO 15189 accreditation.”

 

Mandy Campbell, HORIBA Medical, concluded, “This first multi-site installation of our new HELO modular haematology platform marks another successful step in our long-standing partnership with Cardiff. We are proud that they continue to recognise the quality of our products and support, and are delighted that we have been able to enable their evolving provision of service.”

 

For more information on HORIBA UK Ltd. Medical and its products, please visit: www.horiba.com/uk/medical.

Related

EKF Quo-Test® supports improved medical management of diabetic retinopathy patients

POC HbA1c study at Great Western Hospitals NHS Foundation Trust is finalist for 2019 RCOphth/Bausch...

Read More >

EKF launches PrimeStore® MTM pathogenic sample collection and transportation kit

New sample collection kit enables convenient and safe collection, transportation and handling of pat...

Read More >

Patients Suspected of Sepsis No Longer Need to Wait 5 Days to Rule out Bloodstream Infection with Momentum Bioscience's ETGA® Technology

A study showing how rapid negative exclusion of blood cultures by a molecular method, Cognitor® Minu...

Read More >

EKF signs DiaSpect Tm U.S. distribution agreement with McKesson to launch McKesson Consult® Hb analyzer

FDA cleared POC hemoglobin analyzer to be sold across the USA by the market’s leading and most esta...

Read More >

D-dimer point-of-care testing for DVT considered ‘game-changer’ in ambulatory care

Crawley, UK – 07 February 2019 – Radiometer Limited’s AQT90 FLEX analysers have been used in a su...

Read More >

Invasive Aspergillosis Screening in COVID-19 & Critical Care Patients

IMMY sõna Aspergillus Galactomannan Lateral Flow Assay recommended by the European Confederation of ...

Read More >